Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease
Charles R. Jonassaint,Ektha Parchuri,Julia A. O'Brien,Christina M. Lalama,Jonathan Lin,Sherif M. Badawy,Megan E. Hamm,Jennifer Stinson,Chitra Lalloo,C. Patrick Carroll,Santosh L. Saraf,Victor R. Gordeuk,Robert Cronin,Nirmish Shah,Sophie M. Lanzkron,Darla Liles,Cassandra Trimnell,Lakiea Bailey,Raymona H. Lawrence,Kaleab Z. Abebe
DOI: https://doi.org/10.1111/bjh.19243
2024-01-05
British Journal of Haematology
Abstract:Depressive symptoms are prevalent among patients living with sickle cell disease due to the severity and chronicity of the disease and its impact on their quality of life. Depressive symptoms are also associated with increased pain symptomatology and catastrophizing, and among depressed patients, sickle cell disease has a more detrimental impact on emotional health and social life. Depression may contribute to an increased risk of improperly using opioids due to poor pain control and the decreased effectiveness of these medications. Summary Depressive symptoms are prevalent in individuals living with sickle cell disease (SCD) and may exacerbate pain. This study examines whether higher depressive symptoms are associated with pain outcomes, pain catastrophizing, interference and potential opioid misuse in a large cohort of adults with SCD. The study utilized baseline data from the 'CaRISMA' trial, which involved 357 SCD adults with chronic pain. Baseline assessments included pain intensity, daily mood, the Patient Health Questionnaire (PHQ), the Generalized Anxiety Disorders scale, PROMIS Pain Interference, Pain Catastrophizing Scale, the Adult Sickle Cell Quality of Life Measurement Information System and the Current Opioid Misuse Measure. Participants were categorized into 'high' or 'low' depression groups based on PHQ scores. Higher depressive symptoms were significantly associated with increased daily pain intensity, negative daily mood, higher pain interference and catastrophizing, poorer quality of life and a higher likelihood of opioid misuse (all p
hematology